slides · global inventory
All filtered slides
Global slide inventory for the active corpus filters, with each row opening the slide detail view.
Corpus coverage
319,975 slides
319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.
- Total slides
- 319,975
- Described
- 319,974
- Pending
- 1
100%ready for canon
Slide type composition
dynamicclickable
Slide type
Showing 319,974 described slides — 100.0% of 319,975 rendered pages
+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs
Tile area is proportional to slide count. Click a category to open its subtype map.
all document kinds · all orientations
Slide collection
221,761-221,820 of 319,975
30
The slide highlights the safety profile of the drug candidate, specifically noting the absence of serious adverse events and the nature of injection site reactions.Larimar Therapeutics | Investor Presentation Deck | 44 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
31
MAD = Multiple Ascending Dose. PK = Pharmacokinetics.Larimar Therapeutics | Investor Presentation Deck | 44 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
32
Larimar Therapeutics | Investor Presentation Deck | 44 slidesLarimar Therapeutics | Investor Presentation Deck | 44 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
33
The slide outlines a 28-day treatment schedule with specific administration days highlighted in green.Larimar Therapeutics | Investor Presentation Deck | 44 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
34
The slide presents two visualizations: a dot plot with error bars for longitudinal data and a waterfall plot for individual subject response at Day 14.Larimar Therapeutics | Investor Presentation Deck | 44 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
35
The slide presents two distinct visualizations: a point-range plot for longitudinal data and a waterfall plot for individual subject response.Larimar Therapeutics | Investor Presentation Deck | 44 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
36
The slide highlights that demographics are similar between Phase 1 and Phase 2 trials.Larimar Therapeutics | Investor Presentation Deck | 44 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
37
Data presented as n, mean (SD), median, Q1/Q3, and min/max.Larimar Therapeutics | Investor Presentation Deck | 44 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
38
Larimar Therapeutics | Investor Presentation Deck | 44 slidesLarimar Therapeutics | Investor Presentation Deck | 44 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
39
Larimar Therapeutics | Investor Presentation Deck | 44 slidesLarimar Therapeutics | Investor Presentation Deck | 44 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
40
Kaplan-Meier survival curve showing efficacy of FXN replacement therapy.Larimar Therapeutics | Investor Presentation Deck | 44 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
41
The slide highlights key preclinical efficacy outcomes for the drug candidate CTI-1601.Larimar Therapeutics | Investor Presentation Deck | 44 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
42
Includes two charts: a bar chart for hFXN concentration and a dot plot with error bars for SDH activity.Larimar Therapeutics | Investor Presentation Deck | 44 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
43
Data shows significant differences (****) between vehicle and CTI-1601 treated KO mice.Larimar Therapeutics | Investor Presentation Deck | 44 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
44
The slide uses two line charts to demonstrate efficacy in two different cardiac metrics (Ejection Function and Fractional Shortening) over an 8-week period.Larimar Therapeutics | Investor Presentation Deck | 44 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
01
Legend Biotech | Results Presentation Deck | 15 slidesLegend Biotech | Results Presentation Deck | 15 slides · Legend Biotech
Conference presentation Investor relations Beat · Attention1 hit
02
Legend Biotech | Results Presentation Deck | 15 slidesLegend Biotech | Results Presentation Deck | 15 slides · Legend Biotech
Conference presentation Investor relations Beat · Attention1 hit
03
Legend Biotech | Results Presentation Deck | 15 slidesLegend Biotech | Results Presentation Deck | 15 slides · Legend Biotech
Conference presentation Investor relations Beat · Attention1 hit
04
Legend Biotech | Results Presentation Deck | 15 slidesLegend Biotech | Results Presentation Deck | 15 slides · Legend Biotech
Conference presentation Investor relations Beat · Need1 hit
05
Legend Biotech | Results Presentation Deck | 15 slidesLegend Biotech | Results Presentation Deck | 15 slides · Legend Biotech
Conference presentation Investor relations Beat · Satisfaction1 hit
06
The slide outlines a deal structure involving upfront payments, milestones, royalties, and a division of development labor.Legend Biotech | Results Presentation Deck | 15 slides · Legend Biotech
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test1 hit
07
Legend Biotech | Results Presentation Deck | 15 slidesLegend Biotech | Results Presentation Deck | 15 slides · Legend Biotech
Conference presentation Investor relations Beat · Satisfaction1 hit
08
The chart shows a stacked bar breakdown of U.S. vs EU sales over 6 quarters.Legend Biotech | Results Presentation Deck | 15 slides · Legend Biotech
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
09
The slide uses a grid-based layout to organize clinical trials by stage and therapeutic focus.Legend Biotech | Results Presentation Deck | 15 slides · Legend Biotech
Conference presentation Investor relations Beat · Satisfaction1 hit
10
The slide uses bar charts to compare year-over-year performance, highlighting percentage changes.Legend Biotech | Results Presentation Deck | 15 slides · Legend Biotech
Conference presentation Investor relations Beat · Satisfaction1 hit
11
Legend Biotech | Results Presentation Deck | 15 slidesLegend Biotech | Results Presentation Deck | 15 slides · Legend Biotech
Conference presentation Investor relations Beat · Satisfaction1 hit
12
The chart illustrates a net decrease of $2M ($147M to $145M) driven by R&D savings offset by SG&A and Admin increases.Legend Biotech | Results Presentation Deck | 15 slides · Legend Biotech
Conference presentation Investor relations Beat · Satisfaction1 hit
13
Legend Biotech | Results Presentation Deck | 15 slidesLegend Biotech | Results Presentation Deck | 15 slides · Legend Biotech
Conference presentation Investor relations Beat · Action1 hit
14
Legend Biotech | Results Presentation Deck | 15 slidesLegend Biotech | Results Presentation Deck | 15 slides · Legend Biotech
Conference presentation Investor relations Beat · Action1 hit
15
Legend Biotech | Results Presentation Deck | 15 slidesLegend Biotech | Results Presentation Deck | 15 slides · Legend Biotech
Conference presentation Investor relations Beat · Action1 hit
01
Lenovo | Results Presentation Deck | 18 slidesLenovo | Results Presentation Deck | 18 slides · Lenovo
Conference presentation Investor relations Beat · Setup1 hit
02
Standard SEC-style safe-harbor disclaimer placed near the front of the deck; mostly dense body text with Lenovo branding in the footer.Lenovo | Results Presentation Deck | 18 slides · Lenovo
Conference presentation Investor relations Beat · Setup1 hit
03
Lenovo | Results Presentation Deck | 18 slidesLenovo | Results Presentation Deck | 18 slides · Lenovo
Conference presentation Investor relations Beat · Setup1 hit
04
Includes corporate branding and date.Lenovo | Results Presentation Deck | 18 slides · Lenovo
Conference presentation Investor relations Beat · Setup1 hit
05
Includes footnotes regarding non-PC revenue and non-HKFRS measures.Lenovo | Results Presentation Deck | 18 slides · Lenovo
Conference presentation Investor relations Beat · KPI OverviewLoop · Logic Chain1 hit
06
Includes financial performance indicators and credit rating update.Lenovo | Results Presentation Deck | 18 slides · Lenovo
Conference presentation Investor relations Beat · KPI OverviewLoop · Logic Chain1 hit
07
Includes performance metrics for Q2 22/23 through Q2 23/24.Lenovo | Results Presentation Deck | 18 slides · Lenovo
Conference presentation Investor relations Beat · KPI OverviewLoop · Logic Chain1 hit
08
Includes performance charts for revenue and operating profit/margin, plus market position callouts.Lenovo | Results Presentation Deck | 18 slides · Lenovo
Conference presentation Investor relations Beat · KPI OverviewLoop · Logic Chain1 hit
09
Includes quarterly revenue and operating profit trends, plus key strategic metrics.Lenovo | Results Presentation Deck | 18 slides · Lenovo
Conference presentation Investor relations Beat · KPI OverviewLoop · Logic Chain1 hit
10
The slide uses a 3x4 grid structure to present key performance indicators and milestones.Lenovo | Results Presentation Deck | 18 slides · Lenovo
Conference presentation Investor relations Beat · KPI OverviewLoop · Logic Chain1 hit
11
Lenovo | Results Presentation Deck | 18 slidesLenovo | Results Presentation Deck | 18 slides · Lenovo
Conference presentation Investor relations Beat · Key MessagesLoop · Cost Of Inaction1 hit
12
Lenovo | Results Presentation Deck | 18 slidesLenovo | Results Presentation Deck | 18 slides · Lenovo
Conference presentation Investor relations Beat · Appendix1 hit
13
The table includes both GAAP and non-HKFRS metrics, with year-over-year percentage changes.Lenovo | Results Presentation Deck | 18 slides · Lenovo
Conference presentation Investor relations Beat · Appendix1 hit
14
Lenovo | Results Presentation Deck | 18 slidesLenovo | Results Presentation Deck | 18 slides · Lenovo
Conference presentation Investor relations Beat · Appendix1 hit
15
Lenovo | Results Presentation Deck | 18 slidesLenovo | Results Presentation Deck | 18 slides · Lenovo
Conference presentation Investor relations Beat · Appendix1 hit
16
Lenovo | Results Presentation Deck | 18 slidesLenovo | Results Presentation Deck | 18 slides · Lenovo
Conference presentation Investor relations Beat · Appendix1 hit
17
The table reconciles 'As reported' figures to 'Non-HKFRS' figures by adjusting for fair value changes, amortization of intangible assets, and M&A related charges.Lenovo | Results Presentation Deck | 18 slides · Lenovo
Conference presentation Investor relations Beat · Appendix1 hit
18
Lenovo | Results Presentation Deck | 18 slidesLenovo | Results Presentation Deck | 18 slides · Lenovo
Conference presentation Investor relations Beat · Closing Ask1 hit
01
Limbach Holdings | Investor Presentation Deck | 28 slidesLimbach Holdings | Investor Presentation Deck | 28 slides · Limbach
Pitch deck Investor relations 1 hit
02
Limbach Holdings | Investor Presentation Deck | 28 slidesLimbach Holdings | Investor Presentation Deck | 28 slides · Limbach
Pitch deck Investor relations 1 hit
03
Limbach Holdings | Investor Presentation Deck | 28 slidesLimbach Holdings | Investor Presentation Deck | 28 slides · Limbach
Pitch deck Investor relations 1 hit
04
Uses a hub-and-spoke diagram to center the company's focus on 'Building Owners'.Limbach Holdings | Investor Presentation Deck | 28 slides · Limbach
Pitch deck Investor relations 1 hit
05
The slide uses a comparative structure to highlight the margin difference between GCR (12-15%) and ODR (25-28%).Limbach Holdings | Investor Presentation Deck | 28 slides · Limbach
Pitch deck Investor relations Beat · Problem1 hit
06
Limbach Holdings | Investor Presentation Deck | 28 slidesLimbach Holdings | Investor Presentation Deck | 28 slides · Limbach
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
07
The slide uses a path metaphor to contrast Limbach's focus on optimization against competitors focused on new construction.Limbach Holdings | Investor Presentation Deck | 28 slides · Limbach
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
08
Uses a checkmark/cross matrix to demonstrate competitive advantage.Limbach Holdings | Investor Presentation Deck | 28 slides · Limbach
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
09
The slide uses a 2x2 matrix to illustrate a strategic pivot from a low-margin/low-multiple business model to a high-margin/high-multiple model.Limbach Holdings | Investor Presentation Deck | 28 slides · Limbach
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
10
The slide uses a process-flow diagram to list markets, followed by a three-pillar framework explaining the strategic value of these segments.Limbach Holdings | Investor Presentation Deck | 28 slides · Limbach
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
11
The slide uses a three-column layout to represent the pillars of the business strategy.Limbach Holdings | Investor Presentation Deck | 28 slides · Limbach
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
12
The slide uses a maturity model framework to show the transition from Limbach 1.0 to 3.0.Limbach Holdings | Investor Presentation Deck | 28 slides · Limbach
Pitch deck Investor relations Loop · Cost Of Inaction1 hit